Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Depelestat in Acute Respiratory Distress Syndrome
2006-000756-41Phase 2Completed
- Sponsor
- Debiopharm
- Start
- Mar 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute respiratory distress syndrome (ARDS) comparing Depelestat IV with Placebo IV (2 arms). Primary endpoint: Safety criteria. Started Mar 2006; status: completed.
02
Drugs
depelestat
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on 2006-000756-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000756-41.